Coffee Price Surge to 5 Highlights Global Economic Pressures UK Startup BioOrbit Sends DrugCrystallization Technology to Space for Cancer Treatment Development Kardigan Files for IPO to Fund Heart Disease Drug Pipeline European Shares Climb to OneMonth High on Tech Rally and Geopolitical Optimism Hong Kongs Gold Hub Ambitions Get Boost with New Clearing System Set for July Launch European Shares Flat as US Strikes on Iran Raise Geopolitical Uncertainty METCB Q1 2026 Earnings EPS Misses Estimates Stock Rises Amid Operational Adjustments PriceSmart Inc PSMT Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher AFBI Q3 2023 Earnings Modest EPS of 025 Amid Quiet Quarter BLSH Q1 2026 Earnings EPS Misses Estimates Stock Declines 104 HMC Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment TTWO Q1 2026 Earnings EPS Surges 393 Above Estimates Kura Sushi USA KRUS Holds Steady Near Support as Consolidation Continues ChoiceOne Financial Services COFS Holds Steady Near Support After Minor Decline Acco Group Holdings ACCL Edges Higher as Stock Approaches Key Resistance CO2 Energy Transition Corp Warrant NOEMW Surges 1455 Amid Thin Trading Key Levels Hold at 008 HCMAW Warrants Hold Steady at 059 Amid Low Volatility Arvind Sanger Cautiously Optimistic on India Eyes Earnings Revival Teledyne Technologies TDY Q1 2026 Earnings EPS Surges Past Estimates Despite Sparse Revenue Disclosure Kirby Corporation KEX Narrows Gains Holding Near Resistance Amid Modest Decline Redwood Trust Inc RWT Q1 2026 Earnings EPS Misses Estimates Amidst Quiet Market Reaction FIP Q1 2026 Earnings EPS Misses Estimates Significantly Stock Gains Despite WiderThanExpected Loss NDAQ Q1 2026 Earnings EPS Beats Estimates by 111 Revenue Not Disclosed Shares Edge Higher Indian Indices Edge Higher Amid Mixed Signals Geopolitical Risks Weigh on Sentiment SpaceXs IPO Ambition Hinges on Starlink Revenue Stream Prospectus Reveals Fractyl Health Inc GUTS Q1 2026 Earnings EPS Surprise Beats Estimates as Cash Burn Continues XORTX Therapeutics Q1 2024 Earnings Steep EPS Miss Highlights PreRevenue Biotech Hurdles